Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ocuphire Pharma Inc (NQ: OCUP )

1.170 UNCHANGED
Last Price Updated: 4:00 PM EDT, Oct 23, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Ocuphire Pharma Inc

< Previous 1 2 3 4 Next >
The Week Ahead In Biotech: Mediwound, Provention FDA Decisions, IPOs, Pending Clinical Readouts In Focus
Biotech stocks reversed course and closed the week ended June 25 higher, thanks to the positive broader market sentiment. Eli Lilly and Company (NYSE: LLY) stood out among big... 
Via Benzinga
Exposures Product Safety
Processa Pharmaceuticals In-Licenses Ocuphire's Anticancer Agent
Processa Pharmaceuticals Inc (NASDAQ: PCSA) has entered into a licensing agreement with Ocuphire Pharma Inc (NASDAQ: OCUP) to in-license RX-3117. RX-3117... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Aethlon Medical (NASDAQ:AEMD) sto... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Adamis Pharmaceuticals (NASDAQ:ADMP 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Ocugen (NASDAQ:OCGN) stock moved upwards by 7.1% to $9.95 during Thursday's after-market session. At the close, Ocugen's trading volume reached 7.6 million shares... 
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
During Monday's morning trading, 29 companies set new 52-week lows. Intriguing Points: Ascendis Pharma (NASDAQ:ASND) is the largest company in terms of market... 
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Tuesday morning, 38 companies set new 52-week lows. Key Facts: Viatris (NASDAQ:VTRS) was the largest company by market cap to set a new 52-week low. Enservco (AMEX:... 
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Before 10 a.m. ET Friday, 62 stocks made new 52-week lows. Significant Points: The largest company by market cap to set a new 52-week low was Yatsen Holding (NYSE:... 
Via Benzinga
Ocuphire Pharma Starts Mid-Stage APX3330 Study In Diabetic Retinopathy Patients
Ocuphire Pharma Inc (NASDAQ: OCUP) has screened the first patient in Phase 2 ZETA-1 trial evaluating APX3330 in non-proliferative diabetic... 
Via Benzinga
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.